Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

AbbVie ABBV has built a substantial oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the ...

THE PFIZER Cycle took place once again in Newbridge, and brought together colleagues, families, and the wider community in a ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.

Donald Trump Jr. has joined billionaire entrepreneur Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Pfizer’s Q1 earnings call delivered a rollercoaster of cautious optimism. CEO Albert Bourla credited solid execution in ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

As if Wall Street wasn't troubled enough, the market has been in turmoil across early June thanks to the resurgence of geopolitical unrest in the Middle East. Throw in continued uncertainty ...